Bookmark

Add to MyYahoo RSS

Eli Lilly News

News on Eli Lilly (Ticker: LLY) continually updated from thousands of sources around the net.

Yesterday | AmericanBankingNews.com

Eli Lilly and Given Consensus Recommendation of "Buy" by Brokerages

Eli Lilly and has earned an average recommendation of "Buy" from the twenty-two analysts that are presently covering the stock, Analyst Ratings Network.com reports .

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Imclone Systems, Healthcare Industry, Eli Lilly

Sat Aug 30, 2014

Fredericksburg.com

Getting to Know: Angela Tsai An interview with Angela Tsai, an...

Current job: Optometrist and president of Premier Eyecare, Angela Tsai, O.D. and Associates PC on 230 Butler Road Education/training: I graduated from Indiana UniversityBloomington with my B.S. in Optometry in 2004 as an Eli Lilly Endowment Scholar, a Howard T. Batman Foundation Scholar, a Discover Card Silver Scholar and a Target All-Around ... (more)

Comment?

Related Topix: Optometry, Medicine, Indiana, Biotech, Charitable Organizations, Lilly Endowment, Healthcare Industry, Eli Lilly

Reuters

UPDATE 1-Takeda, Lilly lose bid to overturn $9 bln award for hiding cancer risk

Takeda Pharmaceutical Co Ltd and Eli Lilly & Co lost a bid to overturn a combined $9 billion punitive damage award by a U.S. jury for hiding cancer risks associated with their Actos diabetes drug, according to a court ruling.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Diabetes, Health

Thu Aug 28, 2014

Indianapolis Business News

Lilly, partner lose appeal to overturn $9 billion Actos court award

Takeda Pharmaceutical Co. and Eli Lilly and Co. lost a bid to have a judge throw out a combined $9 billion punitive-damage award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine.

Comment?

Related Topix: Actos, Pioglitazone (generic), Medicine, Biotech, Healthcare Industry, Diabetes, Health

Bloomberg

Takeda, Lilly Lose Bid to Get $9 Billion Actos Award Thrown Out

Takeda Pharmaceutical Co. and Eli Lilly & Co. lost a bid to have a judge throw out a combined $9 billion punitive damage award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine.

Comment?

Related Topix: Actos, Pioglitazone (generic), Medicine, Biotech, Healthcare Industry

The Star Press

Jim Davis and Garfield, some of the Hoosiers whoa

Jim Davis and Garfield, some of the Hoosiers who reinvented themselves As a salute to fresh starts, here are five notable Hoosiers who reinvented themselves.

Comment?

Related Topix: Indiana, Biotech, Medicine, Healthcare Industry, Eli Lilly, Indianapolis, IN, Jennings County, IN

WTHR-TV Indianapolis

IndyCog pushes for 24-hour trail access

IndyCog, a cycling advocacy group, wants the city to allow 24-hour access to the Monon Trail and other city greenways.

Comment?

Related Topix: Monon, IN, Biotech, Medicine, Indianapolis, IN, Healthcare Industry, Eli Lilly

AmericanBankingNews.com

Eli Lilly and Receives Average Recommendation of "Buy" from Analysts

Eli Lilly and has received an average recommendation of "Buy" from the twenty-two analysts that are currently covering the stock, ARN reports .

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Imclone Systems, Healthcare Industry, Eli Lilly

Wed Aug 27, 2014

Barron's

MannKind: Why Jefferies Says Buy

Shares of MannKind have gained 1.8% to $7.47 at 3:49 p.m. today after Jefferies initiated the company at Buy.

Comment?

Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Biotech, Healthcare Industry, Eli Lilly, Diabetes, Health

TheStreet.com

Will This New Rating Help Eli Lilly (LLY) Stock Today?

The bank set a price target of $71 for the drug manufacturer. Eli Lilly is poised to return growth in the coming years according to Deutsche Bank analysts.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets, Business News

TheStreet.com

Will This New Rating Help Eli Lilly (LLY) Stock Today?

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Mozilla, Financial Markets

TheStreet.com

Analysts' Actions: Akamai, Bristol-Myers, Eli Lilly, Merck, Pfizer

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Mozilla, TheStreet

AmericanBankingNews.com

Eli Lilly and Coverage Initiated by Analysts at Deutsche Bank

The firm set a "buy" rating on the stock. Several other analysts have also recently commented on the stock.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Imclone Systems, Healthcare Industry, Eli Lilly

Tue Aug 26, 2014

Benzinga

New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now Available In U.S. Pharmacies

JardianceA tablets are now available by prescription in pharmacies across the United States, including Walgreens, Rite Aid, Kroger and many other leading chain and independent retailers, according to Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company .

Comment?

Related Topix: Medicine, Diabetes, Health, Food and Drug Administration, Biotech, Healthcare Industry, Marketing

Sun Aug 24, 2014

Customer Interaction Solutions

Autonomy deals raise questions as HP row escalates: Files focus on...

Via Acquire Media NewsEdge) Autonomy's $11bn sale to Hewlett-Packard faces further scrutiny after documents cast doubt over the structure of some transactions conducted by the British software firm before its takeover.

Comment?

Related Topix: Startups, Autonomy, Computers, Hewlett Packard, Biotech, Medicine, Healthcare Industry, Eli Lilly, US Governors, Meg Whitman

WTLC-AM Indianapolis

Top Eli Lilly Execs Explain Why Business Community Supports Expanded...

After criticism for not getting involved and engaged in the battle to reduce crime in Indianapolis, the business community has come to the table.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Eli Lilly, Indianapolis, IN

Sat Aug 23, 2014

The Indianapolis Star

Black box' warning on antidepressants vastly reduced lawsuitsa

The days of the big-bucks lawsuits that focused attention on when people commit horrific acts while on antidepressants have pretty much subsided.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Pennsylvania

Fri Aug 22, 2014

Business Journal

Heart to Heart International hires new CEO

Mitchum spent more than 30 years in the pharmaceutical industry with companies such as Eli Lilly & Co ., Marion Laboratories and Hoechst Marion Roussel in Germany.

Comment?

Related Topix: Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Langhorne, PA

Thu Aug 21, 2014

Daily Camera

Broomfield's Corgenix partners with Eli Lilly on diagnostic product

Corgenix Medical Corp., a Broomfield-based developer of diagnostic products including tests to rapidly detect deadly viruses such as Ebola, has entered into a technology transfer, licensing and development agreement with Eli Lilly and Company, regulatory filings show.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Eli Lilly

Reuters

UPDATE 2-Lilly psoriasis drug impresses; battle nears with Amgen, Novartis

An experimental new psoriasis treatment from Eli Lilly and Co proved superior to Amgen Inc's blockbuster Enbrel, drawing it closer to a potential marketing battle with new products being developed by Amgen and Novartis AG.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Psoriasis, Health, Enbrel, Etanercept (generic), Marketing

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••